SMITH ASSET MANAGEMENT GROUP LP - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 58 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 63.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$85,000
+73.5%
57,970
+69.2%
0.00%
+200.0%
Q1 2016$49,000
+14.0%
34,270
+31.4%
0.00%0.0%
Q4 2015$43,000
-12.2%
26,090
+23.6%
0.00%
-50.0%
Q3 2015$49,000
-2.0%
21,100
+16.2%
0.00%0.0%
Q2 2015$50,000
-10.7%
18,156
+9.1%
0.00%0.0%
Q1 2015$56,00016,6340.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders